A pilot study of the use of MaxEPA in haemodialysis patients.
D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control*; D015118:Eicosapentaenoic Acid; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D010974:Platelet Aggregation / Q000187:drug effects; D006435:Renal Dialysis
D005231:Fatty Acids, Unsaturated; D008055:Lipids; D015118:Eicosapentaenoic Acid